Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common degenerative disorder in the elderly in developed countries. Currently, growing evidence is pointing at endothelial dysfunction as a key player in the cognitive decline course of AD. As a main component of the blood–brain barrier (BBB), the dysfunction of...
Main Authors: | Antía Custodia, Marta Aramburu-Núñez, Mariña Rodríguez-Arrizabalaga, Juan Manuel Pías-Peleteiro, Laura Vázquez-Vázquez, Javier Camino-Castiñeiras, José Manuel Aldrey, José Castillo, Alberto Ouro, Tomás Sobrino, Daniel Romaus-Sanjurjo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/6/962 |
Similar Items
-
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Antía Custodia, et al.
Published: (2022-07-01) -
Symmetric and Asymmetric Synapses Driving Neurodegenerative Disorders
by: Daniel Romaus-Sanjurjo, et al.
Published: (2021-12-01) -
Neuroprotection Afforded by an Enriched Mediterranean-like Diet Is Modified by Exercise in a Rat Male Model of Cerebral Ischemia
by: Daniel Romaus-Sanjurjo, et al.
Published: (2024-01-01) -
CHARACTERIZATION OF THE PS19 TAUOPATHY TRANSGENIC MOUSE MODEL AS A PRECLINICAL MODEL TO TEST THERAPEUTIC AND DIAGNOSTIC TARGETS IN ALZHEIMER’S DISEASE.
by: Antía Custodia, et al.
Published: (2023-10-01) -
Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke
by: Antía Custodia, et al.
Published: (2022-09-01)